0,971  0,002  Genotoxic
0,926  0,002  UGT1A9 substrate
0,917  0,004  Mutagenic
0,885  0,002  Antimutagenic
0,877  0,004  Chemoprotective
0,873  0,003  Antihypoxic
0,866  0,002  Monophenol monooxygenase inhibitor
0,858  0,011  Alpha-glucosidase inhibitor
0,838  0,005  Antihypercholesterolemic
0,836  0,005  Carcinogenic
0,827  0,011  Transcription factor NF kappa B inhibitor
0,807  0,002  Melanin inhibitor
0,801  0,002  Amylase inhibitor
0,790  0,003  UGT1A1 substrate
0,783  0,013  Caspase 9 stimulant
0,772  0,006  Chemopreventive
0,765  0,002  Xanthine oxidase inhibitor
0,764  0,005  Antioxidant
0,763  0,006  Sensitization
0,763  0,011  Teratogen
0,746  0,005  Cholesterol antagonist
0,755  0,022  Apoptosis agonist
0,750  0,022  Antiinflammatory
0,734  0,012  Embryotoxic
0,726  0,005  Free radical scavenger
0,728  0,011  Antidiabetic
0,728  0,011  Cyclophilin D inhibitor
0,720  0,007  Antibacterial
0,700  0,003  Mediator release inhibitor
0,690  0,005  Cardioprotectant
0,679  0,005  DNA damaging
0,675  0,006  UGT1A6 substrate
0,674  0,008  Cytostatic
0,668  0,005  Antipyretic
0,669  0,008  NOS2 expression inhibitor
0,666  0,008  Proliferative diseases treatment
0,665  0,015  CYP2C9 substrate
0,648  0,004  Sulfotransferase substrate
0,646  0,006  Hypoglycemic
0,645  0,005  UDP-glucuronosyltransferase substrate
0,646  0,008  Antiparasitic
0,642  0,012  Antithrombotic
0,633  0,004  Skin whitener
0,631  0,005  Angiogenesis stimulant
0,634  0,020  TNF expression inhibitor
0,605  0,002  Hexokinase inhibitor
0,607  0,010  NOS3 expression inhibitor
0,603  0,009  Apoptosis antagonist
0,599  0,012  Cytotoxic
0,581  0,010  Ulceration
0,579  0,016  CYP2C19 substrate
0,569  0,007  Vascular (periferal) disease treatment
0,584  0,026  Antileukemic
0,550  0,005  UGT2B4 substrate
0,551  0,008  RNA-directed DNA polymerase inhibitor
0,552  0,010  DNA synthesis inhibitor
0,556  0,015  Hepatic disorders treatment
0,544  0,003  Protein kinase stimulant
0,549  0,014  Caspase 3 stimulant
0,550  0,019  Antipruritic, allergic
0,565  0,035  Antineoplastic (lung cancer)
0,526  0,007  Interleukin agonist
0,531  0,014  Nitric oxide antagonist
0,555  0,043  Antineoplastic (breast cancer)
0,516  0,006  Non-steroidal antiinflammatory agent
0,516  0,010  Antihypertriglyceridemic
0,507  0,004  Antifungal enhancer
0,528  0,025  Immunostimulant
0,503  0,003  Cyclooxygenase 3 inhibitor
0,503  0,003  Antihemorrhagic
0,504  0,006  Topoisomerase II inhibitor
0,502  0,005  Alkylator
0,503  0,012  Antineoplastic (osteosarcoma)
0,520  0,033  Antineoplastic (colorectal cancer)
0,491  0,006  Antihypotensive
0,507  0,022  Radioprotector
0,502  0,019  Antineoplastic (brain cancer)
0,494  0,014  Amyloid beta aggregation inhibitor
0,482  0,008  Hepatoprotectant
0,496  0,023  Antifungal
0,510  0,039  CYP3A4 substrate
0,503  0,032  Immunosuppressant
0,468  0,003  ATPase inhibitor
0,469  0,005  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,492  0,028  Antineoplastic (ovarian cancer)
0,484  0,023  AR expression inhibitor
0,492  0,035  Antineoplastic (colon cancer)
0,473  0,017  ICAM1 expression inhibitor
0,476  0,022  Antineoplastic (glioma)
0,459  0,006  NOS3 expression enhancer
0,466  0,019  Antiamyloidogenic
0,463  0,019  Antineoplastic (glioblastoma multiforme)
0,472  0,027  Antineoplastic (melanoma)
0,448  0,004  Cystathionine beta-synthase inhibitor
0,475  0,033  Vasodilator, peripheral
0,461  0,021  Vasodilator, coronary
0,443  0,008  Platelet adhesion inhibitor
0,448  0,016  Antineoplastic (liver cancer)
0,466  0,033  Respiratory analeptic
0,472  0,040  Histamine release inhibitor
0,458  0,028  Antineoplastic (cervical cancer)
0,446  0,016  Radiosensitizer
0,447  0,019  Antineoplastic (lymphoma)
0,446  0,020  Tumour necrosis factor alpha release inhibitor
0,431  0,008  Lipid peroxidase inhibitor
0,432  0,013  Antineoplastic (sarcoma)
0,426  0,010  Carcinogenic, group 3
0,450  0,041  Prostate cancer treatment
0,422  0,014  Antihelmintic
0,419  0,014  Cyclic AMP phosphodiesterase inhibitor
0,414  0,010  Interferon gamma antagonist
0,393  0,003  Selectin antagonist
0,415  0,027  Hypoxia-inducible factor 1 alpha inhibitor
0,413  0,030  Antineoplastic (non-small cell lung cancer)
0,417  0,034  Antineoplastic (pancreatic cancer)
0,388  0,005  Aldose reductase substrate
0,403  0,023  Vasodilator
0,399  0,020  Antineoplastic (small cell lung cancer)
0,410  0,036  Analeptic
0,379  0,007  UDP-glucose 4-epimerase inhibitor
0,378  0,006  Topoisomerase I inhibitor
0,395  0,025  Antidiabetic symptomatic
0,377  0,013  Antiviral (Influenza)
0,370  0,008  Acute respiratory distress syndrome (ARDS) treatment
0,392  0,030  Interleukin 2 agonist
0,385  0,026  Myocardial infarction treatment
0,362  0,004  Mannose-6-phosphate isomerase inhibitor
0,371  0,020  Septic shock treatment
0,368  0,018  Antiviral (Herpes)
0,362  0,015  DNA methylase inhibitor
0,349  0,004  DNA repair enzyme inhibitor
0,352  0,012  Peptidyltransferase inhibitor
0,342  0,005  Topoisomerase II alpha inhibitor
0,339  0,004  Antiviral (Influenza B)
0,342  0,008  Aldehyde dehydrogenase inhibitor
0,343  0,010  Neurotrophic factor enhancer
0,345  0,015  VCAM1 expression inhibitor
0,333  0,005  Antineoplastic, alkylator
0,332  0,008  Antineoplastic antibiotic
0,355  0,031  Antineoplastic (endocrine cancer)
0,325  0,005  Beta glucuronidase inhibitor
0,327  0,007  Expectorant
0,330  0,013  Hemostatic
0,351  0,035  Antineoplastic (renal cancer)
0,321  0,005  Carbonic anhydrase XIII inhibitor
0,305  0,004  Photosensitizer
0,343  0,042  Antiprotozoal (Leishmania)
0,368  0,069  Stroke treatment
0,312  0,014  Antidote
0,317  0,019  Antipruritic, non-allergic
0,301  0,005  AMP-activated protein kinase stimulant
0,299  0,003  Heat shock protein 70 antagonist
0,341  0,046  Antidiabetic (type 2)
0,311  0,020  Antineoplastic (squamous cell carcinoma)
0,314  0,024  UGT2B7 substrate
0,302  0,013  Glutathione S-transferase substrate
0,344  0,058  Antimycobacterial
0,303  0,018  Muscular dystrophy treatment
0,339  0,056  Spasmolytic
0,291  0,010  Cell wall synthesis inhibitor
0,322  0,043  Transcription factor STAT3 inhibitor
0,297  0,018  UGT2B15 substrate
0,293  0,019  Antineoplastic (gastric cancer)
0,299  0,026  DNA methyltransferase I inhibitor
0,285  0,013  DNA intercalator
0,308  0,040  Antineoplastic (lymphocytic leukemia)
0,355  0,089  Antiprotozoal
0,320  0,054  Antineoplastic (multiple myeloma)
0,278  0,013  DNA polymerase I inhibitor
0,279  0,025  Acaricide
0,269  0,020  Interleukin 6 antagonist
0,255  0,006  Antirickettsial
0,357  0,109  5 Hydroxytryptamine release inhibitor
0,256  0,009  Antibiotic
0,268  0,021  Antiviral (Influenza A)
0,261  0,026  Nitric-oxide synthase stimulant
0,238  0,007  HIV-1 integrase (3'-Processing) inhibitor
0,232  0,004  Phosphodiesterase 6D inhibitor
0,254  0,028  Diabetic nephropathy treatment
0,225  0,004  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,252  0,033  Insulin sensitizer
0,293  0,079  Antiischemic
0,235  0,022  Neuropathy treatment
0,219  0,008  HIV-1 integrase (Strand Transfer) inhibitor
0,241  0,033  Antineoplastic (carcinoma)
0,262  0,055  Antiulcerative
0,276  0,070  Transcription factor STAT inhibitor
0,292  0,087  Immunomodulator
0,221  0,017  Antibacterial (Helicobacter pylori)
0,213  0,009  Triose-phosphate isomerase inhibitor
0,215  0,011  Carbonic anhydrase VI inhibitor
0,346  0,142  Antineoplastic (solid tumors)
0,223  0,020  Antitussive
0,209  0,008  Thioredoxin inhibitor
0,226  0,027  Alpha-N-acetylglucosaminidase inhibitor
0,232  0,036  UGT1A3 substrate
0,208  0,013  Antispirochetal
0,209  0,015  Choleretic
0,211  0,017  Antifungal (Cryptococcus)
0,245  0,051  Wound healing agent
0,218  0,028  Insulin secretagoues
0,207  0,020  Toll-Like receptor 2 antagonist
0,291  0,105  Antiprotozoal (Plasmodium)
0,226  0,041  Thrombolytic
0,266  0,082  Lipoprotein disorders treatment
0,200  0,016  Carbonic anhydrase III inhibitor
0,243  0,059  Antiviral (HIV)
0,189  0,008  Toll-Like receptor 4 antagonist
0,210  0,031  NADPH oxidase inhibitor
0,318  0,140  Antiarthritic
0,226  0,050  P-glycoprotein inhibitor
0,190  0,015  Vanilloid 1 agonist
0,180  0,004  Antibiotic Glycopeptide-like
0,210  0,040  Antiacne
0,198  0,029  Psychosexual dysfunction treatment
0,181  0,012  NADH dehydrogenase inhibitor
0,201  0,035  Antidiarrheal
0,176  0,012  Transcription factor NF kappa B stimulant
0,263  0,099  CYP2D6 substrate
0,208  0,044  Protein-tyrosine phosphatase inhibitor
0,208  0,047  Antiviral (Ebola)
0,180  0,020  UGT2B1 substrate
0,226  0,067  Antineoplastic enhancer
0,160  0,004  Antimycoplasmal
0,168  0,015  Ca2+-transporting ATPase inhibitor
0,255  0,105  CTGF expression inhibitor
0,163  0,013  Antiviral (Trachoma)
0,188  0,038  Alkaline phosphatase inhibitor
0,186  0,037  Skin irritative effect
0,178  0,032  Cell adhesion inhibitor
0,178  0,032  Gout treatment
0,301  0,157  Calcium channel L-type activator
0,215  0,072  Antialcoholic
0,146  0,005  Carbonic anhydrase XIV inhibitor
0,153  0,012  CDC25A inhibitor
0,214  0,074  Pyruvate kinase inhibitor
0,144  0,005  Fatty acid synthase inhibitor
0,147  0,008  ATPase (Vacuolar H+) inhibitor
0,180  0,042  Antiseptic
0,163  0,026  Mucolytic
0,170  0,035  Interleukin 4 antagonist
0,158  0,027  Antineoplastic (uterine cancer)
0,252  0,121  Angiogenesis inhibitor
0,132  0,002  Sodium/glucose cotransporter inhibitor
0,150  0,021  Actinic keratosis treatment
0,140  0,012  Aldose reductase inhibitor
0,162  0,034  Carcinogenic, group 2B
0,230  0,104  Antituberculosic
0,134  0,009  Xanthine dehydrogenase inhibitor
0,234  0,111  Lipoxygenase inhibitor
0,124  0,002  Sodium/glucose cotransporter 2 inhibitor
0,146  0,024  Uric acid excretion stimulant
0,161  0,039  Antihelmintic (Trematoda)
0,179  0,058  Restenosis treatment
0,161  0,041  Protein-tyrosine phosphatase 1B inhibitor
0,168  0,049  CF transmembrane conductance regulator agonist
0,129  0,012  Antiviral (Dengue virus)
0,145  0,028  Dementia treatment
0,119  0,002  Sodium/glucose cotransporter 1 inhibitor
0,139  0,024  Alcohol dehydrogenase inhibitor
0,140  0,027  Vascular dementia treatment
0,122  0,010  Phosphorylase inhibitor
0,136  0,023  NAD(P)H dehydrogenase (quinone) inhibitor
0,138  0,026  Carcinogenic, group 2A
0,171  0,062  Cystic fibrosis treatment
0,124  0,016  Histone deacetylase SIRT1 stimulant
0,124  0,016  Histone deacetylase stimulant
0,226  0,121  CYP1A2 substrate
0,121  0,016  Na+ K+ transporting ATPase inhibitor
0,216  0,113  Antineoplastic (bladder cancer)
0,108  0,011  Protein 50S ribosomal subunit inhibitor
0,110  0,014  Neuraminidase (influenza) inhibitor
0,171  0,075  Antineoplastic (bone cancer)
0,111  0,015  Phosphodiesterase VI inhibitor
0,136  0,042  TRPA1 agonist
0,166  0,076  Mcl-1 antagonist
0,140  0,050  Cholesterol synthesis inhibitor
0,107  0,019  T cell inhibitor
0,172  0,086  Antiviral (Hepatitis)
0,101  0,015  CDC25B inhibitor
0,117  0,032  Interleukin 12 antagonist
0,112  0,027  Phosphofructokinase-1 inhibitor
0,266  0,182  DNA directed DNA polymerase inhibitor
0,138  0,053  Antiviral (Hepatitis B)
0,160  0,076  Antihelmintic (Nematodes)
0,086  0,004  Protein 30S ribosomal subunit inhibitor
0,090  0,008  Alpha-mannosidase inhibitor
0,186  0,105  Hypolipemic
0,136  0,055  Adenylate cyclase inhibitor
0,128  0,047  Chelator
0,105  0,024  GABA aminotransferase inhibitor
0,162  0,082  Dual specificity phosphatase inhibitor
0,128  0,049  Antifungal (Pneumocystis)
0,103  0,026  Thioredoxin reductase inhibitor
0,087  0,012  Topoisomerase II beta inhibitor
0,078  0,005  Antibiotic Aminoglycoside-like
0,081  0,009  Squalene epoxidase inhibitor
0,126  0,055  Microtubule formation inhibitor
0,080  0,009  Mannosidase inhibitor
0,167  0,097  Anesthetic general
0,129  0,060  Growth stimulant
0,097  0,031  Interferon agonist
0,074  0,009  Heparanase inhibitor
0,086  0,021  Neuraminidase inhibitor
0,149  0,084  Carcinogenic, group 1
0,157  0,093  Phospholipase C inhibitor
0,075  0,012  Adenine nucleotide translocase inhibitor
0,092  0,030  HIV-1 integrase inhibitor
0,130  0,068  Retinoprotector
0,137  0,077  Hair growth stimulant
0,081  0,021  Nitric oxide donor
0,065  0,005  Cholesterol absorption inhibitor
0,094  0,038  Glycine receptor antagonist
0,098  0,044  Interleukin 5 antagonist
0,116  0,063  Estrogen antagonist
0,174  0,122  Platelet antagonist
0,152  0,101  Catenin beta inhibitor
0,053  0,003  Vanilloid 2 agonist
0,089  0,039  Telomerase inhibitor
0,067  0,018  Glucose-6-phosphate translocase inhibitor
0,108  0,060  HDL-cholesterol increasing
0,105  0,057  Chronic obstructive bronchitis treatment
0,106  0,059  5-Lipoxygenase inhibitor
0,073  0,030  Interferon inducer
0,061  0,018  Glucose-6-phosphate isomerase inhibitor
0,120  0,079  Antihyperlipoproteinemic
0,089  0,049  Vanilloid agonist
0,069  0,030  Maillard reaction inhibitor
0,095  0,056  SULT1E1 substrate
0,067  0,030  Protein kinase C eta inhibitor
0,067  0,033  Transcription factor AP-1 inhibitor
0,078  0,046  Antitreponemal
0,080  0,048  Keratolytic
0,034  0,003  Antibiotic Anthracycline-like
0,054  0,024  Carbonic anhydrase VII inhibitor
0,060  0,030  Estrogen agonist
0,130  0,102  UGT2B9 substrate
0,058  0,031  DNA helicase inhibitor
0,058  0,032  Alpha tubulin antagonist
0,189  0,164  Bone diseases treatment
0,048  0,023  Guanylate cyclase inhibitor
0,077  0,055  Arylamine N-Acetyltransferase substrate
0,185  0,165  Antipsoriatic
0,055  0,034  Leukotriene B4 antagonist
0,110  0,090  Tubulin antagonist
0,087  0,069  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,124  0,107  Eye irritation, high
0,051  0,033  Equilibrative nucleoside transport protein inhibitor
0,088  0,070  Antiviral (Rhinovirus)
0,124  0,106  Antidiabetic (type 1)
0,124  0,107  UGT1A4 substrate
0,144  0,127  Antimitotic
0,049  0,032  Adenosine deaminase inhibitor
0,130  0,115  Liver fibrosis treatment
0,121  0,106  SULT1A3 substrate
0,036  0,021  Tubulin agonist
0,121  0,107  Antiprotozoal (Coccidial)
0,088  0,074  Anticataract
0,018  0,005  Antibiotic Tetracycline-like
0,056  0,045  Lipocortins synthesis agonist
0,122  0,111  Heat shock protein 90 antagonist
0,052  0,041  Postmenopausal disorders treatment
0,018  0,010  Telomerase stimulant
0,072  0,064  Narcotic antagonist
0,028  0,021  1,3-Beta-glucan synthase inhibitor
0,084  0,078  Glutamate release inhibitor
0,127  0,120  Dual specificity phosphatase 3 inhibitor
0,026  0,020  Toll-Like receptor 4 agonist
0,043  0,037  Microtubule stabilization
0,222  0,218  Antineoplastic (myeloid leukemia)
0,168  0,165  Huntington's disease treatment
0,042  0,039  Neuraminidase (Influenza A) inhibitor
0,032  0,030  Arginase inhibitor
0,028  0,028  Elastase 2B inhibitor
0,028  0,028  Elastase 3B inhibitor
0,028  0,028  Elastase 3A inhibitor
0,046  0,046  Factor III inhibitor

